section name header

Basics

Telogen Effluvium (also Discussed in Chapter 19: Hair and Scalp Disorders Resulting in Hair Loss)

Clinical Manifestations

Clinical Variant

Occipital alopecia of the newborn (Telogen effluvium of the newborn)

  • Occipital alopecia of the newborn occurring at 3 to 4 months of age is an asymptomatic, ill-defined patch of alopecia localized to the posterior occipital scalp (Fig. 9.6).

  • After the first few days of life, anagen hairs convert into telogen hairs and as a result a higher proportion of occipital scalp hairs are shed during the first 4 months of life, creating a noticeable patch of alopecia on the posterior scalp.

  • Friction created by rubbing the posterior scalp on the pillow or mattress is also a factor.

  • Clinically, the presentation varies from a small patch of relative alopecia to a larger area of complete alopecia.

  • Spontaneous complete recovery occurs within months, no treatment is required.

Diagnosis

Management-icon.jpg Management

  • If the trigger has been removed, complete regrowth is expected within months.

  • If the underlying trigger is sustained, telogen effluvium can become chronic.

  • Careful discussion with parents about the cause of the condition and its favorable natural history is usually all that is needed.

  • Shedding typically stops in 3 to 6 months and complete regrowth may take another 6 months.

  • No treatment is necessary and no treatment is uniformly effective.

  • However, topical minoxidil 2%, 1 mL applied to the scalp twice daily can promote transition back to anagen.

Helpful-Hint-icon.jpg Helpful Hints

  • Occasionally TE can unmask androgenetic alopecia in predisposed individuals and a new baseline hair density is set when the TE episode resolves.

  • Blood tests for a possible underlying cause should be guided by history and physical examination if there are no obvious triggers.

  • Rate of scalp hair growth is 0.3 mm/day or 1 cm/month.